- Cancer Care Team
Cancer Care Team
To deliver optimal patient outcomesProducts and Services
Cancer Type
Supplies & Tools
Scientific Focus
- Biopharma Partners
- Patients
- Education & Events
- Login
- Contact Us
SOLID TUMORS
OmniSeq INSIGHT® is a comprehensive genomic and immune profiling test validated for all solid tumors. Next generation sequencing interrogates 523 genes for mutations, 4 copy number alterations and 55 fusions/splice variants, and determines microsatellite instability (MSI), homologous recombination deficiency (HRD) when clinically indicated, and tumor mutational burden (TMB). Immunohistochemistry determines PD-L1 expression. The test informs treatment decisions, including targeted and immunotherapy options, eligibility for clinical trials, and mechanisms of therapy resistance based on the genomic and immune profile of a patient’s tumor.
Labcorp Oncology
700 Ellicott St
Buffalo, NY 14203
Fax: 888-770-4931
Call Client Services at
(800) 781-1259
Online ordering and result reporting